Chem/Phys Resistance

Temp. Limits: -10 °C to 200 °C isothermal, 220 °C programmed

General description

CHIRALDEX B-DA requires that analytes possess a minimum of two ring structures, one of which is unsaturated (aromatic) α, β to the stereogenic center. Examples include fluoxetine, methylphenidate and chloropheniramine. Inclusion complexation or proper fit between the analyte and cyclodextrin cavity is the dominant enantioselectivity mechanism for the DA series. There must be an includable group α or β to the stereogenic center for chiral recognition. Since CHIRALDEX DA columns most effectively separate multi-ring analytes, analysis temperatures are often higher than 150°C. Enantioselectivity has been observed at temperatures >200°C (fluoxetine acetyl derivative).

Legal Information

CHIRALDEX is a trademark of Sigma-Aldrich Co. LLC

Astec is a registered trademark of Sigma-Aldrich Co. LLC

Other Notes

We offer a variety of chromatography accessories including analytical syringes